Oakworth Capital’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $853 | Hold |
20
| – | – | ﹤0.01% | 897 |
|
|
2026
Q1 | $964 | Hold |
20
| – | – | ﹤0.01% | 822 |
|
|
2025
Q4 | $969 | Hold |
20
| – | – | ﹤0.01% | 826 |
|
|
2025
Q3 | $944 | Sell |
20
-10
| -33% | -$483 | ﹤0.01% | 788 |
|
|
2025
Q2 | $1.45K | Sell |
30
-144
| -83% | -$7.36K | ﹤0.01% | 583 |
|
|
2025
Q1 | $9.65K | Buy |
174
+144
| +480% | +$7.79K | ﹤0.01% | 519 |
|
|
2024
Q4 | $1.45K | Hold |
30
| – | – | ﹤0.01% | 586 |
|
|
2024
Q3 | $1.73K | Hold |
30
| – | – | ﹤0.01% | 618 |
|
|
2024
Q2 | $1.46K | Hold |
30
| – | – | ﹤0.01% | 683 |
|
|
2024
Q1 | $1.46K | Buy |
+30
| New | +$1.47K | ﹤0.01% | 649 |
|
|
2022
Q3 | – | Sell |
-430
| Closed | -$22K | – | 574 |
|
|
2022
Q2 | $22K | Sell |
430
-20
| -4% | -$1.06K | ﹤0.01% | 376 |
|
|
2022
Q1 | $23K | Sell |
450
-100
| -18% | -$5.16K | ﹤0.01% | 372 |
|
|
2021
Q4 | $28K | Sell |
550
-104
| -16% | -$5.14K | ﹤0.01% | 388 |
|
|
2021
Q3 | $32K | Hold |
654
| – | – | ﹤0.01% | 358 |
|
|
2021
Q2 | $34K | Hold |
654
| – | – | ﹤0.01% | 356 |
|
|
2021
Q1 | $32K | Buy |
+654
| New | +$31.4K | ﹤0.01% | 354 |
|
|
2018
Q1 | – | Sell |
-887
| Closed | -$40K | – | 644 |
|
|
2017
Q4 | $40K | Hold |
887
| – | – | 0.01% | 307 |
|
|
2017
Q3 | $43K | Hold |
887
| – | – | 0.01% | 311 |
|
|
2017
Q2 | $42K | Hold |
887
| – | – | 0.01% | 307 |
|
|
2017
Q1 | $40K | Hold |
887
| – | – | 0.01% | 302 |
|
|
2016
Q4 | $36K | Sell |
887
-140
| -14% | -$5.52K | 0.01% | 299 |
|
|
2016
Q3 | $39K | Sell |
1,027
-124
| -11% | -$4.98K | 0.01% | 284 |
|
|
2016
Q2 | $47K | Buy |
1,151
+271
| +31% | +$11.1K | 0.02% | 259 |
|
|
2016
Q1 | $35K | Hold |
880
| – | – | 0.01% | 246 |
|
|
2015
Q4 | $38K | Hold |
880
| – | – | 0.02% | 217 |
|
|
2015
Q3 | $42K | Hold |
880
| – | – | 0.02% | 170 |
|
|
2015
Q2 | $48K | Hold |
880
| – | – | 0.02% | 164 |
|
|
2015
Q1 | $44K | Hold |
880
| – | – | 0.02% | 197 |
|
|
2014
Q4 | $40K | Hold |
880
| – | – | 0.02% | 197 |
|
|
2014
Q3 | $48K | Hold |
880
| – | – | 0.03% | 139 |
|
|
2014
Q2 | $47K | Hold |
880
| – | – | 0.03% | 140 |
|
|
2014
Q1 | $46K | Buy |
880
+616
| +233% | +$31.2K | 0.03% | 139 |
|
|
2013
Q4 | $14K | Buy |
+264
| New | +$13.6K | 0.01% | 240 |
|
Other funds holding SNY
MIP
BIP
Oakworth Capital's SNY Position: Q2 2026 in Review
Oakworth Capital held its Sanofi (SNY) position steady in Q2 2026 at 20 shares worth $853. The position accounts for ﹤0.01% of the portfolio, ranked #897.
Oakworth Capital first reported a position in SNY in Q4 2013 and has held it in 33 quarters since. The position peaked at $48K in Q2 2015. 718 funds tracked by Wall St. Rank hold SNY as of Q2 2026.
- Oakworth Capital held 20 shares of Sanofi worth $853 as of Q2 2026.
- Oakworth Capital left its Sanofi share count unchanged in Q2 2026.
- Sanofi made up ﹤0.01% of Oakworth Capital's portfolio in Q2 2026, its #897 holding.
- Oakworth Capital first reported a position in Sanofi in Q4 2013 and has held it in 33 quarters since.
- Oakworth Capital's Sanofi position peaked at $48K in Q2 2015.
- 718 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.
Based on Oakworth Capital's 13F filing for Q2 2026, filed 22 Jul 2026.